MicuRx Pharmaceuticals

MicuRx is a biopharmaceutical company focused on novel treatments for infectious diseases. With global proprietary intellectual property and strong competitiveness, we are committed to the discovery, development, and commercialization of innovative drugs to address unmet medical needs. Since its establishment in 2007, MicuRx has adhered to the principle of "Quality Medicines, Better Treatment," concentrating on the growing global issue of antimicrobial resistance. With solving clinical problems as our core competence and differentiated innovation as our goal, we aim to provide more effective and safer treatment options for patients with the most common and severe drug-resistant bacterial infections. MicuRx Pharmaceuticals is a U.S.-based subsidiary of Shanghai Micon Pharmaceutics Co., Ltd.